Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 86

1.

Dissecting molecular mechanisms of resistance to Notch1-targeted therapy in T-cell acute lymphoblastic leukemia xenografts.

Agnusdei V, Minuzzo S, Pinazza M, Gasparini A, Pezzè L, Amaro AA, Pasqualini L, Del Bianco P, Tognon M, Frasson C, Palumbo P, Ciribilli Y, Pfeffer U, Carella M, Amadori A, Indraccolo S.

Haematologica. 2019 Aug 29. pii: haematol.2019.217687. doi: 10.3324/haematol.2019.217687. [Epub ahead of print]

2.

Rivaroxaban Versus Warfarin and Renal Outcomes in Non-valvular Atrial Fibrillation Patients with Diabetes.

Hernandez AV, Bradley G, Khan M, Fratoni A, Gasparini A, Roman YM, Bunz TJ, Eriksson D, Meinecke AK, Coleman CI.

Eur Heart J Qual Care Clin Outcomes. 2019 Aug 20. pii: qcz047. doi: 10.1093/ehjqcco/qcz047. [Epub ahead of print]

PMID:
31432074
3.

Effectiveness and safety of abatacept for the treatment of patients with primary Sjögren's syndrome.

Machado AC, Dos Santos LC, Fidelix T, Lekwitch I, Soares SB, Gasparini AF, Augusto JV, Junior NC, Trevisani VFM.

Clin Rheumatol. 2019 Aug 16. doi: 10.1007/s10067-019-04724-w. [Epub ahead of print]

PMID:
31420813
4.

Impact of model misspecification in shared frailty survival models.

Gasparini A, Clements MS, Abrams KR, Crowther MJ.

Stat Med. 2019 Oct 15;38(23):4477-4502. doi: 10.1002/sim.8309. Epub 2019 Jul 21.

PMID:
31328285
5.

Oral Antipsychotic Versus Long-Acting Injections Antipsychotic in Schizophrenia Spectrum Disorder: a Mirror Analysis in a Real-World Clinical Setting.

Poloni N, Ielmini M, Caselli I, Lucca G, Gasparini A, Gasparini A, Lorenzoli G, Callegari C.

Psychopharmacol Bull. 2019 Jun 20;49(2):17-27.

PMID:
31308579
6.

Characterization of intellectual disability and autism comorbidity through gene panel sequencing.

Aspromonte MC, Bellini M, Gasparini A, Carraro M, Bettella E, Polli R, Cesca F, Bigoni S, Boni S, Carlet O, Negrin S, Mammi I, Milani D, Peron A, Sartori S, Toldo I, Soli F, Turolla L, Stanzial F, Benedicenti F, Marino-Buslje C, Tosatto SCE, Murgia A, Leonardi E.

Hum Mutat. 2019 Sep;40(9):1346-1363. doi: 10.1002/humu.23822. Epub 2019 Aug 2.

PMID:
31209962
7.

The 6-D Model of National Culture as a Tool to Examine Cultural Interpretation of Migration Trauma-Related Dissociative Disorder: A Case Series.

Callegari C, Ielmini M, Caselli I, Mattia M, Gasparini A, Grossi A, Ceccon F, Poloni N.

J Immigr Minor Health. 2019 Jun 4. doi: 10.1007/s10903-019-00904-7. [Epub ahead of print]

PMID:
31165366
8.

Twenty years of Lithium pharmacogenetics: A systematic review.

Pagani R, Gasparini A, Ielmini M, Caselli I, Poloni N, Ferrari M, Marino F, Callegari C.

Psychiatry Res. 2019 Aug;278:42-50. doi: 10.1016/j.psychres.2019.05.036. Epub 2019 May 23. Review.

PMID:
31146140
9.

Micro cone beam computed tomography for sensitive assessment of radiation-induced late lung toxicity in preclinical models.

van Berlo D, Khmelinskii A, Gasparini A, Salguero FJ, Floot B, de Wit N, van de Ven M, Song JY, Coppes RP, Verheij M, Sonke JJ, Vens C.

Radiother Oncol. 2019 Sep;138:17-24. doi: 10.1016/j.radonc.2019.05.007. Epub 2019 May 27.

PMID:
31146069
10.

Causes of death across categories of estimated glomerular filtration rate: The Stockholm CREAtinine Measurements (SCREAM) project.

Runesson B, Qureshi AR, Xu H, Gasparini A, Lindholm B, Barany P, Elinder CG, Carrero JJ.

PLoS One. 2019 Jan 16;14(1):e0209440. doi: 10.1371/journal.pone.0209440. eCollection 2019.

11.

Vascular Forum: collective intelligence in the resolution of vascular clinical cases.

Erzinger FL, de Araujo WJB, Ordinola AAM, Gasparini AF, da Luz AVT, Kamada DM, Amato ACM.

J Vasc Bras. 2018 Jul-Sep;17(3):193-200. doi: 10.1590/1677-5449.005018.

12.

Radiosensitivity Is an Acquired Vulnerability of PARPi-Resistant BRCA1-Deficient Tumors.

Barazas M, Gasparini A, Huang Y, Küçükosmanoğlu A, Annunziato S, Bouwman P, Sol W, Kersbergen A, Proost N, de Korte-Grimmerink R, van de Ven M, Jonkers J, Borst GR, Rottenberg S.

Cancer Res. 2019 Feb 1;79(3):452-460. doi: 10.1158/0008-5472.CAN-18-2077. Epub 2018 Dec 10.

13.

Genetic, Epigenetic, and Immunologic Profiling of MMR-Deficient Relapsed Glioblastoma.

Indraccolo S, Lombardi G, Fassan M, Pasqualini L, Giunco S, Marcato R, Gasparini A, Candiotto C, Nalio S, Fiduccia P, Fanelli GN, Pambuku A, Della Puppa A, D'Avella D, Bonaldi L, Gardiman MP, Bertorelle R, De Rossi A, Zagonel V.

Clin Cancer Res. 2019 Mar 15;25(6):1828-1837. doi: 10.1158/1078-0432.CCR-18-1892. Epub 2018 Dec 4.

PMID:
30514778
14.

Plasma potassium ranges associated with mortality across stages of chronic kidney disease: the Stockholm CREAtinine Measurements (SCREAM) project.

Gasparini A, Evans M, Barany P, Xu H, Jernberg T, Ärnlöv J, Lund LH, Carrero JJ.

Nephrol Dial Transplant. 2019 Sep 1;34(9):1534-1541. doi: 10.1093/ndt/gfy249.

15.

Reversible splenial lesion in neuroleptic malignant syndrome.

Gasparini A, Poloni N, Caselli I, Ielmini M, Callegari C.

Panminerva Med. 2018 Sep;60(3):134-135. doi: 10.23736/S0031-0808.18.03434-1. Epub 2018 Apr 24. No abstract available.

16.

A scheme based on ICD-10 diagnoses and drug prescriptions to stage chronic kidney disease severity in healthcare administrative records.

Friberg L, Gasparini A, Carrero JJ.

Clin Kidney J. 2018 Apr;11(2):254-258. doi: 10.1093/ckj/sfx085. Epub 2017 Aug 2.

17.

Lower serum calcium is independently associated with CKD progression.

Janmaat CJ, van Diepen M, Gasparini A, Evans M, Qureshi AR, Ärnlöv J, Barany P, Elinder CG, Rotmans JI, Vervloet M, Dekker FW, Carrero JJ.

Sci Rep. 2018 Mar 26;8(1):5148. doi: 10.1038/s41598-018-23500-5.

18.

Cinacalcet use and the risk of cardiovascular events, fractures and mortality in chronic kidney disease patients with secondary hyperparathyroidism.

Evans M, Methven S, Gasparini A, Barany P, Birnie K, MacNeill S, May MT, Caskey FJ, Carrero JJ.

Sci Rep. 2018 Feb 1;8(1):2103. doi: 10.1038/s41598-018-20552-5.

19.

eGFR and the Risk of Community-Acquired Infections.

Xu H, Gasparini A, Ishigami J, Mzayen K, Su G, Barany P, Ärnlöv J, Lindholm B, Elinder CG, Matsushita K, Carrero JJ.

Clin J Am Soc Nephrol. 2017 Sep 7;12(9):1399-1408. doi: 10.2215/CJN.00250117. Epub 2017 Aug 17.

20.

Dynamic scaffolds for neuronal signaling: in silico analysis of the TANC protein family.

Gasparini A, Tosatto SCE, Murgia A, Leonardi E.

Sci Rep. 2017 Jul 28;7(1):6829. doi: 10.1038/s41598-017-05748-5.

21.

Incidence and determinants of hyperkalemia and hypokalemia in a large healthcare system.

Nilsson E, Gasparini A, Ärnlöv J, Xu H, Henriksson KM, Coresh J, Grams ME, Carrero JJ.

Int J Cardiol. 2017 Oct 15;245:277-284. doi: 10.1016/j.ijcard.2017.07.035. Epub 2017 Jul 15.

22.

Outcomes associated to serum phosphate levels in patients with suspected acute coronary syndrome.

Xu H, Evans M, Gasparini A, Szummer K, Spaak J, Ärnlöv J, Lindholm B, Jernberg T, Carrero JJ.

Int J Cardiol. 2017 Oct 15;245:20-26. doi: 10.1016/j.ijcard.2017.07.050. Epub 2017 Jul 17.

PMID:
28734575
23.

Hyperkalemia After Initiating Renin-Angiotensin System Blockade: The Stockholm Creatinine Measurements (SCREAM) Project.

Bandak G, Sang Y, Gasparini A, Chang AR, Ballew SH, Evans M, Arnlov J, Lund LH, Inker LA, Coresh J, Carrero JJ, Grams ME.

J Am Heart Assoc. 2017 Jul 19;6(7). pii: e005428. doi: 10.1161/JAHA.116.005428.

24.

Working toward precision medicine: Predicting phenotypes from exomes in the Critical Assessment of Genome Interpretation (CAGI) challenges.

Daneshjou R, Wang Y, Bromberg Y, Bovo S, Martelli PL, Babbi G, Lena PD, Casadio R, Edwards M, Gifford D, Jones DT, Sundaram L, Bhat RR, Li X, Pal LR, Kundu K, Yin Y, Moult J, Jiang Y, Pejaver V, Pagel KA, Li B, Mooney SD, Radivojac P, Shah S, Carraro M, Gasparini A, Leonardi E, Giollo M, Ferrari C, Tosatto SCE, Bachar E, Azaria JR, Ofran Y, Unger R, Niroula A, Vihinen M, Chang B, Wang MH, Franke A, Petersen BS, Pirooznia M, Zandi P, McCombie R, Potash JB, Altman RB, Klein TE, Hoskins RA, Repo S, Brenner SE, Morgan AA.

Hum Mutat. 2017 Sep;38(9):1182-1192. doi: 10.1002/humu.23280. Epub 2017 Jul 7.

25.

Association Between Proton Pump Inhibitor Use and Risk of Progression of Chronic Kidney Disease.

Klatte DCF, Gasparini A, Xu H, de Deco P, Trevisan M, Johansson ALV, Wettermark B, Ärnlöv J, Janmaat CJ, Lindholm B, Dekker FW, Coresh J, Grams ME, Carrero JJ.

Gastroenterology. 2017 Sep;153(3):702-710. doi: 10.1053/j.gastro.2017.05.046. Epub 2017 Jun 2.

PMID:
28583827
26.

Lessons from the CAGI-4 Hopkins clinical panel challenge.

Chandonia JM, Adhikari A, Carraro M, Chhibber A, Cutting GR, Fu Y, Gasparini A, Jones DT, Kramer A, Kundu K, Lam HYK, Leonardi E, Moult J, Pal LR, Searls DB, Shah S, Sunyaev S, Tosatto SCE, Yin Y, Buckley BA.

Hum Mutat. 2017 Sep;38(9):1155-1168. doi: 10.1002/humu.23225. Epub 2017 Jun 12.

27.
28.

Time in Therapeutic Range and Outcomes After Warfarin Initiation in Newly Diagnosed Atrial Fibrillation Patients With Renal Dysfunction.

Szummer K, Gasparini A, Eliasson S, Ärnlöv J, Qureshi AR, Bárány P, Evans M, Friberg L, Carrero JJ.

J Am Heart Assoc. 2017 Mar 1;6(3). pii: e004925. doi: 10.1161/JAHA.116.004925.

29.

Low renal replacement therapy incidence among slowly progressing elderly chronic kidney disease patients referred to nephrology care: an observational study.

Lundström UH, Gasparini A, Bellocco R, Qureshi AR, Carrero JJ, Evans M.

BMC Nephrol. 2017 Feb 10;18(1):59. doi: 10.1186/s12882-017-0473-1.

30.

Increased strength of the scapular stabilizer and lumbar muscles after twelve weeks of Pilates training using the Reformer machine: A pilot study.

Dos Santos NT, Raimundo KC, da Silva SA, Souza LA, Ferreira KC, Borges Santo Urbano ZF, Gasparini AL, Bertoncello D.

J Bodyw Mov Ther. 2017 Jan;21(1):74-80. doi: 10.1016/j.jbmt.2016.05.005. Epub 2016 Jun 1.

PMID:
28167194
31.

Corrigendum: DisProt 7.0: a major update of the database of disordered proteins.

Piovesan D, Tabaro F, Mičetić I, Necci M, Quaglia F, Oldfield CJ, Aspromonte MC, Davey NE, Davidović R, Dosztányi Z, Elofsson A, Gasparini A, Hatos A, Kajava AV, Kalmar L, Leonardi E, Lazar T, Macedo-Ribeiro S, Macossay-Castillo M, Meszaros A, Minervini G, Murvai N, Pujols J, Roche DB, Salladini E, Schad E, Schramm A, Szabo B, Tantos A, Tonello F, Tsirigos KD, Veljković N, Ventura S, Vranken W, Warholm P, Uversky VN, Dunker AK, Longhi S, Tompa P, Tosatto SC.

Nucleic Acids Res. 2017 Jan 4;45(D1):D1123-D1124. doi: 10.1093/nar/gkw1279. Epub 2016 Dec 13. No abstract available.

32.

Albuminuria changes are associated with subsequent risk of end-stage renal disease and mortality.

Carrero JJ, Grams ME, Sang Y, Ärnlöv J, Gasparini A, Matsushita K, Qureshi AR, Evans M, Barany P, Lindholm B, Ballew SH, Levey AS, Gansevoort RT, Elinder CG, Coresh J.

Kidney Int. 2017 Jan;91(1):244-251. doi: 10.1016/j.kint.2016.09.037. Epub 2016 Dec 4.

33.

DisProt 7.0: a major update of the database of disordered proteins.

Piovesan D, Tabaro F, Mičetić I, Necci M, Quaglia F, Oldfield CJ, Aspromonte MC, Davey NE, Davidović R, Dosztányi Z, Elofsson A, Gasparini A, Hatos A, Kajava AV, Kalmar L, Leonardi E, Lazar T, Macedo-Ribeiro S, Macossay-Castillo M, Meszaros A, Minervini G, Murvai N, Pujols J, Roche DB, Salladini E, Schad E, Schramm A, Szabo B, Tantos A, Tonello F, Tsirigos KD, Veljković N, Ventura S, Vranken W, Warholm P, Uversky VN, Dunker AK, Longhi S, Tompa P, Tosatto SC.

Nucleic Acids Res. 2017 Jan 4;45(D1):D219-D227. doi: 10.1093/nar/gkw1056. Epub 2016 Nov 28. Erratum in: Nucleic Acids Res. 2017 Jan 4;45(D1):D1123-D1124.

34.

Prevalence and recognition of chronic kidney disease in Stockholm healthcare.

Gasparini A, Evans M, Coresh J, Grams ME, Norin O, Qureshi AR, Runesson B, Barany P, Ärnlöv J, Jernberg T, Wettermark B, Elinder CG, Carrero JJ.

Nephrol Dial Transplant. 2016 Dec;31(12):2086-2094. Epub 2016 Oct 13.

35.

Scrambler Therapy(®) MC-5A for Complex Regional Pain Syndrome: Case Reports.

Raucci U, Tomasello C, Marri M, Salzano M, Gasparini A, Conicella E.

Pain Pract. 2016 Sep;16(7):E103-9. doi: 10.1111/papr.12474. Epub 2016 Jul 2.

PMID:
27370908
36.

Concomitant targeting of programmed death-1 (PD-1) and CD137 improves the efficacy of radiotherapy in a mouse model of human BRAFV600-mutant melanoma.

Kroon P, Gadiot J, Peeters M, Gasparini A, Deken MA, Yagita H, Verheij M, Borst J, Blank CU, Verbrugge I.

Cancer Immunol Immunother. 2016 Jun;65(6):753-63. doi: 10.1007/s00262-016-1843-4. Epub 2016 May 9.

37.

The Stockholm CREAtinine Measurements (SCREAM) project: protocol overview and regional representativeness.

Runesson B, Gasparini A, Qureshi AR, Norin O, Evans M, Barany P, Wettermark B, Elinder CG, Carrero JJ.

Clin Kidney J. 2016 Feb;9(1):119-27. doi: 10.1093/ckj/sfv117. Epub 2015 Nov 14.

38.

First Italian Ebola virus disease case: management of hospital internal and external communication.

Salce L, Barbato S, Renna D, Bianchini F, Vaccaro P, Mazzeo F, Gasparini A, Rizza C, Lanfranchi E, Petrosillo N, Nicastri E, Di Caro A, Capobianchi MR, Puro V, Ippolito G; INMI EBOV Team.

New Microbiol. 2015 Oct;38(4):565-70. Epub 2015 Oct 20.

39.

First isolation of enteroaggregative Escherichia coli O104:H4 from a diarrhea case in Argentina.

Carbonari CC, Deza N, Flores M, Gasparini A, Manfredi E, Rivas M.

Rev Argent Microbiol. 2014 Oct-Dec;46(4):302-6. doi: 10.1016/S0325-7541(14)70086-0.

40.

The curative outcome of radioimmunotherapy in a mouse breast cancer model relies on mTOR signaling.

Verbrugge I, Gasparini A, Haynes NM, Hagekyriakou J, Galli M, Stewart TJ, Abrams SI, Yagita H, Verheij M, Johnstone RW, Borst J, Neefjes J.

Radiat Res. 2014 Aug;182(2):219-29. doi: 10.1667/RR13511.1. Epub 2014 Jun 24. Erratum in: Radiat Res. 2014 Oct;182(4):e45.

PMID:
24960417
41.

Multi-institutional dosimetric and geometric commissioning of image-guided small animal irradiators.

Lindsay PE, Granton PV, Gasparini A, Jelveh S, Clarkson R, van Hoof S, Hermans J, Kaas J, Wittkamper F, Sonke JJ, Verhaegen F, Jaffray DA.

Med Phys. 2014 Mar;41(3):031714. doi: 10.1118/1.4866215.

PMID:
24593718
42.

Diffusion-weighted magnetic resonance imaging in focal breast lesions: analysis of 78 cases with pathological correlation.

Fornasa F, Pinali L, Gasparini A, Toniolli E, Montemezzi S.

Radiol Med. 2011 Mar;116(2):264-75. doi: 10.1007/s11547-010-0602-4. Epub 2010 Oct 6. English, Italian.

PMID:
21076884
43.

Sublingual immunotherapy in polysensitized patients: effect on quality of life.

Ciprandi G, Cadario G, Valle C, Ridolo E, Verini M, Di Gioacchino M, Minelli M, Gangemi S, Sillano V, Colangelo C, Pravettoni V, Pellegrino R, Borrelli P, Fiorina A, Carosso A, Gasparini A, Riario-Sforza GG, Incorvaia C, Puccinelli P, Scurati S, Frati F.

J Investig Allergol Clin Immunol. 2010;20(4):274-9.

44.

Sublingual immunotherapy in children with allergic polysensitization.

Ciprandi G, Cadario G, Di Gioacchino GM, Gangemi S, Gasparini A, Isola S, Marengo F, Minelli S, Ricciardi L, Ridolo E, Pravettoni V, Valle C, Verini M, Zambito M, Incorvaia C, Puccinelli P, Scurati S, Frati F, Simonetta M.

Allergy Asthma Proc. 2010 May-Jun;31(3):227-31. doi: 10.2500/aap.2010.31.3337.

PMID:
20615323
45.

Altered microstructure integrity of the amygdala in schizophrenia: a bimodal MRI and DWI study.

Tomasino B, Bellani M, Perlini C, Rambaldelli G, Cerini R, Isola M, Balestrieri M, Calì S, Versace A, Pozzi Mucelli R, Gasparini A, Tansella M, Brambilla P.

Psychol Med. 2011 Feb;41(2):301-11. doi: 10.1017/S0033291710000875. Epub 2010 May 12.

PMID:
20459886
46.

Changes in cerebral activity after decreased upper-limb hypertonus: an EMG-fMRI study.

Manganotti P, Acler M, Formaggio E, Avesani M, Milanese F, Baraldo A, Storti SF, Gasparini A, Cerini R, Mucelli RP, Fiaschi A.

Magn Reson Imaging. 2010 Jun;28(5):646-52. doi: 10.1016/j.mri.2009.12.023. Epub 2010 Feb 1.

PMID:
20117894
47.

Enhancement of superconductivity near the ferromagnetic quantum critical point in UCoGe.

Slooten E, Naka T, Gasparini A, Huang YK, de Visser A.

Phys Rev Lett. 2009 Aug 28;103(9):097003. Epub 2009 Aug 26.

PMID:
19792821
48.

Muon spin rotation and relaxation in the superconducting ferromagnet UCoGe.

de Visser A, Huy NT, Gasparini A, de Nijs DE, Andreica D, Baines C, Amato A.

Phys Rev Lett. 2009 Apr 24;102(16):167003. Epub 2009 Apr 22.

PMID:
19518746
49.

Characteristics of patients with allergic polysensitization: the POLISMAIL study.

Ciprandi G, Alesina R, Ariano R, Aurnia P, Borrelli P, Cadario G, Capristo A, Carosso A, Casino G, Castiglioni G, Cesinaro Di Rocco P, Colangelolo C, Di Gioacchino M, Di Paola MG, Errico G, Fiorina A, Gambuzza F, Gangemi S, Gasparini A, Giugno R, Iemoli E, Isola S, Maniero G, Marengo F, Mazzali P, Minelli M, Mosca M, Pellegrino R, Piconi S, Pravettoni V, Quaglio L, Ricciardi L, Ridolo E, Sillano V, Valle C, Varin E, Verini M, Zambito M, Riario-Sforza GG, Incorvaia C, Puccinelli P, Scurati S, Frati F.

Eur Ann Allergy Clin Immunol. 2008 Nov;40(3):77-83.

PMID:
19334371
50.

Effect of a Static Magnetic Field (1.5T) on Brain Oscillatory Activities in Resting State Condition.

Formaggio E, Avesani M, Storti SF, Milanese F, Gasparini A, Acler M, Cerini R, Pozzi Mucelli R, Fiaschi A, Manganotti P.

Neuroradiol J. 2008 Dec 17;21(5):629-35. Epub 2008 Dec 17.

PMID:
24257003

Supplemental Content

Loading ...
Support Center